GL1X · GenesisL1 explorer

UniProt O96935

M1 family aminopeptidase (O96935)

M1 family aminopeptidase (UniProt O96935), EC 3.4.11.-: 79 experimental structures and 1 predicted model on GenesisL1, 17 ligands bound, 67 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
O96935
Protein
M1 family aminopeptidase
EC
3.4.11.-
Experimental structures
79
Predicted models
1
Ligands
17
Pockets
67 · 6 records with a druggable one

Structures

80 records of O96935 in the MolNFT archive: 79 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
3EBGStructure of the M1 Alanylaminopeptidase from malariax-ray diffractionA——
3EBGStructure of the M1 alanylaminopeptidase from malariax-ray diffractionA——
3EBHStructure of the M1 Alanylaminopeptidase from malaria complexed with bestatinx-ray diffractionA——
3EBHStructure of the M1 alanylaminopeptidase from malaria complexed with bestatinx-ray diffractionA——
3EBIStructure of the M1 Alanylaminopeptidase from malaria complexed with the phosphinate dipeptide…x-ray diffractionA——
3EBIStructure of the M1 alanylaminopeptidase from malaria complexed with the phosphinate dipeptide…x-ray diffractionA——
3Q43X-ray crystal structure of PfA-M1 bound to bestatin derivative 15x-ray diffractionA——
3Q43X-ray crystal structure of pfa-M1 bound to bestatin derivative 15x-ray diffractionA——
3Q44X-ray crystal structure of PfA-M1 bound to Bestatin derivative 16x-ray diffractionA——
3Q44X-ray crystal structure of pfa-M1 bound to bestatin derivative 16x-ray diffractionA——
3T8VA bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family…x-ray diffractionA——
3T8VA bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family…x-ray diffractionA——
4J3BA naturally variable residue in the S1 subsite of M1-family aminopeptidases modulates catalytic…x-ray diffractionA——
4J3BA naturally variable residue in the S1 subsite of M1-family aminopeptidases modulates catalytic…x-ray diffractionA——
4K5LPhosphonic Arginine Mimetics as Inhibitors of the M1 Aminopeptidases from Plasmodium falciparumx-ray diffractionA——
4K5LPhosphonic arginine mimetics as inhibitors of the M1 aminopeptidases from plasmodium falciparumx-ray diffractionA——
4K5MPhosphonic Arginine Mimetics as Inhibitors of the M1 Aminopeptidases from Plasmodium falciparumx-ray diffractionA——
4K5MPhosphonic arginine mimetics as inhibitors of the M1 aminopeptidases from plasmodium falciparumx-ray diffractionA——
4K5NPhosphonic Arginine Mimetics as Inhibitors of the M1 Aminopeptidases from Plasmodium falciparumx-ray diffractionA——
4K5NPhosphonic arginine mimetics as inhibitors of the M1 aminopeptidases from plasmodium falciparumx-ray diffractionA——
4K5OPhosphonic Arginine Mimetics as Inhibitors of the M1 Aminopeptidases from Plasmodium falciparumx-ray diffractionA——
4K5OPhosphonic arginine mimetics as inhibitors of the M1 aminopeptidases from plasmodium falciparumx-ray diffractionA——
4K5PPhosphonic Arginine Mimetics as Inhibitors of the M1 Aminopeptidases from Plasmodium falciparumx-ray diffractionA——
4K5PPhosphonic arginine mimetics as inhibitors of the M1 aminopeptidases from plasmodium falciparumx-ray diffractionA——
4R5TStructure of the m1 alanylaminopeptidase from malaria complexed with a hydroxamic acid-based…x-ray diffractionA——
4R5TStructure of the M1 alanylaminopeptidase from malaria complexed with a hydroxamic acid-based…x-ray diffractionA——
4R5VStructure of the m1 alanylaminopeptidase from malaria complexed with a hydroxamic acid-based…x-ray diffractionA——
4R5VStructure of the M1 alanylaminopeptidase from malaria complexed with a hydroxamic acid-based…x-ray diffractionA——
4R5XStructure of the m1 alanylaminopeptidase from malaria complexed with a hydroxamic acid-based…x-ray diffractionA——
4R5XStructure of the M1 alanylaminopeptidase from malaria complexed with a hydroxamic acid-based…x-ray diffractionA——
4X2UX-ray crystal structure of the orally available aminopeptidase inhibitor, Tosedostat, bound to the…x-ray diffractionA——
4X2UX-ray crystal structure of the orally available aminopeptidase inhibitor, tosedostat, bound to the…x-ray diffractionA——
4ZQTCrystal structure of PfA-M1 with virtual ligand inhibitorx-ray diffractionA4QP, ZN, MG13 (best 0.80)
4ZQTCrystal structure of pfa-M1 with virtual ligand inhibitorx-ray diffractionA——
4ZW3X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 9bx-ray diffractionA——
4ZW3X-ray crystal structure of pfa-M1 in complex with hydroxamic acid- based inhibitor 9Bx-ray diffractionA——
4ZW5X-ray crystal structure of pfa-M1 in complex with hydroxamic acid- based inhibitor 9Fx-ray diffractionA——
4ZW6X-ray crystal structure of pfa-M1 in complex with hydroxamic acid- based inhibitor 9Qx-ray diffractionA——
4ZW7X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 9mx-ray diffractionA——
4ZW7X-ray crystal structure of pfa-M1 in complex with hydroxamic acid- based inhibitor 9Mx-ray diffractionA——
4ZW8X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 9rx-ray diffractionA——
4ZW8X-ray crystal structure of pfa-M1 in complex with hydroxamic acid- based inhibitor 9Rx-ray diffractionA——
4ZX3X-ray crystal structure of pfa-M1 in complex with hydroxamic acid- based inhibitor 10Bx-ray diffractionA——
4ZX4X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 10ox-ray diffractionA——
4ZX4X-ray crystal structure of pfa-M1 in complex with hydroxamic acid- based inhibitor 10Ox-ray diffractionA——
4ZX5X-ray crystal structure of pfa-M1 in complex with hydroxamic acid- based inhibitor 10Qx-ray diffractionA——
4ZX6X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 10sx-ray diffractionA——
4ZX6X-ray crystal structure of pfa-M1 in complex with hydroxamic acid- based inhibitor 10Sx-ray diffractionA——
5XM7Crystal structure of Plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAZN, MG, 89X—
5XM7Crystal structure of plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAZN, MG, 89X—
5Y19Crystal structure of Plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAZN, MG—
5Y19Crystal structure of plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAZN, MG—
5Y1HCrystal structure of Plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAMG, ZN, E8C9 (best 0.79)
5Y1HCrystal structure of plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAMG, ZN, E8C—
5Y1KCrystal structure of plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAZN, MG, B1B—
5Y1QCrystal structure of plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAZN, MG, 8L0—
5Y1RCrystal structure of plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAZN, MG—
5Y1SCrystal structure of plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAZN, MG, E8F, E8R—
5Y1TCrystal structure of plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAZN, MG, E8G—
5Y1VCrystal structure of Plasmodium falciparum aminopeptidase N in complex with…x-ray diffractionAZN, MG—

20 records more on the page itself.

Ligands

  • MG · Magnesium ion · in 32 records
  • ZN · Zinc ion · in 32 records
  • PO4 · Phosphate ion · in 6 records
  • 89X · (2S)-4-methyl-N-[(1R)-2-(oxidanylamino)-2-oxidanylidene-1-phenyl-ethyl]-2-[(phenylmethyl) carbamoylamino]pentanamide · in 2 records
  • BB2 · Actinonin · in 2 records
  • E8C · (2R)-2-[[2,4-bis(fluoranyl) phenyl]methylcarbamoylamino]-4-methyl-N-oxidanyl-pentanamide · in 2 records
  • 4QP · (2R)-2-{[(R)-[(R)-amino(phenyl)methyl](hydroxy)phosphoryl]methyl}-4-methylpentanoic acid · in 1 record
  • 8L0 · (2S)-2-[(3-chlorophenyl)methylcarbamoylamino]-4-methyl-N-oxidanyl-pentanamide · in 1 record
  • 8N3 · (2R)-4-methyl-2-[(3-methylphenyl)methylcarbamoylamino]-N-oxidanyl-pentanamide · in 1 record
  • B1B · (2S)-2-[(2-chlorophenyl)methylcarbamoylamino]-4-methyl-N-oxidanyl-pentanamide · in 1 record
  • BYW · 2-hydroxy-N-[(1R)-2-(hydroxyamino)-2-oxo-1-(3',4',5'-trifluoro[1,1'-biphenyl]-4-yl)ethyl]-2-methylpropanamide · in 1 record
  • E8F · (2S)-2-[(3,4-dimethylphenyl)methylcarbamoylamino]-4-methyl-N-oxidanyl-pentanamide · in 1 record
  • E8G · (2S)-2-[(2,3-dimethylphenyl)methylcarbamoylamino]-4-methyl-N-oxidanyl-pentanamide · in 1 record
  • E8R · (2R)-2-[(3,4-dimethylphenyl)methylcarbamoylamino]-4-methyl-N-oxidanyl-pentanamide · in 1 record
  • J0Y · (2R)-2,3,3,3-tetrafluoro-N-[(1R)-2-(hydroxyamino)-2-oxo-1-(3',4',5'-trifluoro[1,1'-biphenyl]-4-yl)ethyl]propanamide · in 1 record
  • X0I · (2R)-2-(cyclopentylcarbamamido)-N-hydroxy-2-(3',4',5'-trifluoro[1,1'-biphenyl]-4-yl)acetamide · in 1 record
  • X10 · N-[(1R)-2-(hydroxyamino)-2-oxo-1-(3',4',5'-trifluoro[1,1'-biphenyl]-4-yl)ethyl]-N~2~-phenylglycinamide · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.